Kontrol Tech Investigating Potential BioCloud Patent Infringement
Kontrol Technologies (NEO: KNR) is reportedly investigating a potential patent infringement on its BioCloud technology. The revelation was quietly included
Read moreKontrol Technologies (NEO: KNR) is reportedly investigating a potential patent infringement on its BioCloud technology. The revelation was quietly included
Read more2022 appears to be the year that wasn’t for Kontrol Technologies (NEO: KNR). The firm this morning cancelled previously issued
Read moreKontrol Technologies (NEO: KNR) has obtained credit from a Schedule 1 bank, enabling it to repay certain debentures due in
Read moreKontrol Technologies (NEO: KNR) has seen a slight revenue decline on a quarter over quarter basis. The firm this morning
Read moreKontrol Technologies (NEO: KNR) is looking to add additional funds to company coffers. The firm last night revealed that it
Read moreIt appears that Kontrol Technologies (NEO: KNR) is backing away from one of its key strategic initiatives for 2022. While
Read moreKontrol Technologies Corp. (NEO: KNR) released two major pieces of news this week that point to the potential outlook of
Read moreKontrol Technologies (NEO: KNR) this morning indicated it has secured a major contract through its recently acquired subsidiary. The contract
Read moreKontrol Technologies Corp. (NEO: KNR) released on Monday its financial statements for the quarter ending on June 30, 2020. The
Read moreKontrol Technologies (NEO: KNR) is set to resume trading this morning following a halt on Wednesday. The halt was a
Read more